Rosacea, Erythematotelangiectatic study: Vascular laser treatment
Official title Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy
ClinicalTrials.gov ID: NCT07521462
What this study is testing
- What it's testing
- This study is testing whether a dermocosmetic product can lower facial redness and visible blood vessels in rosacea patients. It also looks at how it works when used with laser therapy.
- Who it's for
- You may be able to join if you have rosacea that causes redness and visible blood vessels on your face.
- What's involved
- You will apply the cream to one side of your face and a pretend cream to the other side, twice a day for two months. After that, you may use the cream with laser treatment. You will visit the clinic regularly for check‑ups and to fill out questionnaires.
- Time commitment
- The study lasts about two months of daily cream use, plus extra visits for laser treatment and follow‑up check‑ups.
You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Gender: male or female
- Age: \> 18 years -Patients with mild to severe erythro-couperotic rosacea (stage 2, 3, or 4 - TRoSA scale, section 2.2.3.1)
- Patients wishing to undergo vascular laser treatments for their rosacea
- Patients who have provided informed consent
You likely can't join if
- Pregnant patients or patients with a positive urine pregnancy test at the initial visit
- Patients with another condition in the study area.
- Patients who have received laser treatment for the same condition within the previous 12 months.
- Patients with another form of rosacea (e.g., papules and pustules, ocular rosacea, etc.).
- Patients using another anti-redness product on the face during the study.
- Patients who have taken photosensitizing treatments during the month prior to study enrollment.
See the full eligibility criteria
- Gender: male or female
- Age: \> 18 years -Patients with mild to severe erythro-couperotic rosacea (stage 2, 3, or 4 - TRoSA scale, section 2.2.3.1)
- Patients wishing to undergo vascular laser treatments for their rosacea
- Patients who have provided informed consent
- Pregnant patients or patients with a positive urine pregnancy test at the initial visit
- Patients with another condition in the study area.
- Patients who have received laser treatment for the same condition within the previous 12 months.
- Patients with another form of rosacea (e.g., papules and pustules, ocular rosacea, etc.).
- Patients using another anti-redness product on the face during the study.
- Patients who have taken photosensitizing treatments during the month prior to study enrollment.
- Patients taking or having taken oral isotretinoin within 6 months prior to study enrollment.
- Patients enrolled in another study.
- Adult patients under a legal guardianship arrangement (guardianship, conservatorship, judicial protection).
- Patients not covered by social security.
The study team makes the final eligibility decision.
Where it is enrolling
- Rouen, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Rouen, France. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.